According to Zion Market Research, the global nicotine replacement therapy market size was $44.5 billion in 2021. By 2028, demand for the global nicotine replacement therapy market size and share is expected to reach $103.4 billion with a compound annual growth rate (CAGR) of 15.1%.
List of Key Players in the Nicotine Replacement Therapy Market:
Chipla Corporation.
Pfizer Inc.
Johnson Service Company
British American Tobacco Company
Philip Morris Products S.A. (part of the Altria Group)
Empire brand
Sorry, I cannot translate this phrase to English as it seems to be a name written in Chinese characters and there is no context provided to determine its meaning.
Japan Tobacco Inc.
Overview of the Nicotine Replacement Therapy Market
Nicotine replacement therapy, which involves using low-dose nicotine products like patches, inhalers, gums, sprays, and lozenges that do not contain harmful substances found in tobacco, is becoming increasingly popular among smokers. This approach aims to reduce or eliminate tobacco use, which is known to cause chronic health problems like lung cancer and asthma due to its high nicotine content. The rising popularity of NRT is driven largely by public awareness of the harmful effects of smoking. As smoking rates continue to rise worldwide, governments are implementing measures like the Affordable Care Act, insurance rules, and awareness campaigns to encourage smokers to quit. Additionally, advancements in NRT technology are leading more people to turn to cutting-edge products like heat-not-burn devices, sweet gums, and lozenges, which are expected to accelerate the adoption of NRT. However, one of the biggest obstacles to NRT market expansion is the ban on e-cigarettes.
Key industry insights and findings of the nicotine replacement therapy market report:
According to analysis shared by our research analysts, the market for nicotine replacement therapy is expected to grow at a CAGR of approximately 15.1% annually between 2022 and 2028.
According to initial research, the estimated value of the nicotine replacement therapy market in 2021 is approximately $44.5 billion, with a projected increase to around $103.4 billion by 2028.
The increase in smoking-related diseases and government measures supporting smoking, as well as the growing acceptance of electronic cigarettes and heated tobacco, are expected to have a positive impact on the development of the North American market.
The number of smokers complying with smoking bans in the region is on the rise, leading to a stronger demand for products such as chewing gum and inhalers. In addition, the smoking cessation rate in the United States is higher than in other countries, resulting in an increase in sales volume for these products.
According to a survey conducted by the Centers for Disease Control and Prevention (CDC), approximately 68% of Americans have decided to quit smoking. Therefore, it is expected that this will increase product sales in the coming years.
One major factor driving the growth of the global nicotine replacement therapy market is the increasing awareness of the dangers of smoking worldwide.
Industry news:
The Nicotine Replacement Therapy Market: Growing Driving Factors and an Increasing Understanding of the Detrimental Effects of Smoking are Driving Market Growth.
Public awareness of the harmful effects of smoking is expected to become a key market driver. More than 1.1 billion people worldwide smoke. Government initiatives, such as the Affordable Care Act, insurance requirements, and campaigns to raise awareness of the harmful effects of smoking through education, have contributed to the use of nicotine replacement therapies. Favorable reimbursement policies will further accelerate the global expansion of the nicotine replacement therapy market.
Despite widespread awareness of the negative effects of smoking spread through awareness programs, TV commercials, leaflets and other means, the number of people wanting to quit smoking has decreased. In addition, although successful NRT treatments have been introduced and public awareness has been improved, product intake rates are still very low. According to research by the World Health Organization (WHO), there are myths about these products. These include the belief that the products are ineffective, have negative effects, and are costly. As a result, current misconceptions about these items have reduced their adoption rates, leading to a decline in sales.
Global Nicotine Replacement Therapy Market: Segmentation. The global nicotine replacement therapy market has been segmented based on product, distribution channel, and geography.
The global market for nicotine replacement therapy products is classified into inhalers, chewing gum, transdermal patches, lozenges, sublingual tablets, e-cigarettes, and smokeless tobacco products. In 2021, e-cigarettes held the largest market share at 52.1%. It is expected that more and more people will become aware that e-cigarettes are safer than traditional cigarettes, especially among the younger generation, which will further drive market growth. The wide range of customizable options offered by suppliers, including temperature control and nicotine dosage, is expected to contribute to increased demand for the product. In addition, the rapidly growing technology of e-cigarettes has become increasingly popular, increasing user satisfaction.
The global market for nicotine replacement therapy is divided into offline and online distribution channels. In 2021, the offline sub-market had the highest revenue share at 83.9%. The growth of the sub-market is being fueled by the increase in NRT products such as transdermal patches, gels, gum, e-cigarettes, and heated tobacco products in retail chains like Walgreens and Walmart Stores, Inc. Additionally, the connection between hospitals and these retail chains is aiding in the expansion of the business.
In 2021, North America dominated the nicotine replacement therapy market.
The prevalence of smoking-related diseases, increased government support for smoking, and higher acceptance of electronic cigarettes and heated tobacco are expected to have a favorable impact on the development of the North American market. This region has the highest retail sales of NRT products in the United States and Canada. The number of smokers adhering to smoking bans in the region is increasing, leading to stronger demand for products such as gum and inhalers. Additionally, the smoking cessation rate in the United States is higher than in other countries, resulting in increased sales of these products. Approximately 68% of Americans have decided to quit smoking, according to a survey conducted by the Centers for Disease Control and Prevention (CDC), which is expected to increase product sales in the coming years. Additionally, in the United States, gum is more commonly used than other treatment methods for smoking cessation in the market.
Statement:
This article is compiled based on third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The translation of this article is solely intended for industry professionals to exchange and conduct research.
Due to limitations in the level of translation, the translated article may not fully reflect the expression of the original article. Please refer to the original article for accuracy.
2FIRSTS maintains a consistent stance with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, or foreign-related issues and statements.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to request deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
